[Current approaches in the treatment and rehabilitation of patients with neurological diseases after COVID-19. Resolution of the International Experts Forum].
O S LevinV V VashchilinSlaven PikijaDina R KhasanovaSaule TuruspekovaA N BogolepovaA A ShmoninM N MaltcevaIgor VoznyukS N YanishevskijD K HuseynovYulia KarakulovaF Kh ObidovPublished in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2023)
Despite the significant shift in global attention away from the pandemic, the problem of a new coronavirus infection remains important in the medical community. Almost 3 years after the start of the COVID-19 pandemic the issues of rehabilitation and management of delayed manifestations and sequelae of the disease are especially important. According to numerous available data, the new coronavirus infection is characterized by multiorgan lesions. Respiratory dysfunction, clotting disorders, myocardial dysfunction and various arrhythmias, acute coronary syndrome, acute renal failure, GI disorders, hepatocellular damage, hyperglycemia and ketosis, dermatological complications, ophthalmological symptoms and neurological disorders may be found. Significant prevalence of the latter in the post-coronavirus period necessitated this International Expert Forum to develop unified approaches to the management of patients with neurological complications and sequelae of new coronavirus infection based on practical experience and considering the scientific information available on COVID-19. The expert council developed a resolution formulating the tactics for the management of patients with neurological manifestations of COVID-19.
Keyphrases
- sars cov
- coronavirus disease
- respiratory syndrome coronavirus
- acute coronary syndrome
- oxidative stress
- risk factors
- healthcare
- mental health
- cerebral ischemia
- single molecule
- working memory
- liver failure
- clinical practice
- left ventricular
- heart failure
- intensive care unit
- physical activity
- depressive symptoms
- antiplatelet therapy
- congenital heart disease
- percutaneous coronary intervention
- blood brain barrier
- hepatitis b virus
- social media
- diabetic rats
- replacement therapy
- smoking cessation